Get the tools used by (smart)2 investors.

Debt / Common Equity for Ekso Bionics Holdings Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

EKSO: Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provi...

0.41 USD
Price
USD
Fair Value
Upside
0.34 - 1.53
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Ekso Bionics Holdings Inc's Debt / Common Equity:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0%50.0%100.0%150.0%200.0%

Performance Summary
  • Ekso Bionics's debt / equity last quarter was 47.1%
  • Ekso Bionics's debt / equity for fiscal years ending December 2020 to 2024 averaged 45.3%.
  • Ekso Bionics's operated at median debt / equity of 47.1% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Ekso Bionics's debt / equity peaked in December 2020 at 87.0%.
  • Ekso Bionics's debt / equity hit its 5-year low in December 2021 of 6.0%.
  • Ekso Bionics's debt / equity decreased in 2021 (6.0%, -93.1%) and 2024 (47.1%, -17.2%) and increased in 2020 (87.0%, +52.7%), 2022 (29.5%, +394.1%), and 2023 (56.9%, +92.8%).

How does Ekso Bionics's Debt / Common Equity benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Ekso Bionics Holdings Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Debt / Equity

Hide this widget
debt_to_equity
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Debt / Common Equity in the risk category include:

  • Degree of Combined Leverage (DCL) - The degree of combined leverage expands on the degree of operating leverage to provide a view of a company's ability to generate profits from sales. It multiplies DOL and DFL.
  • Beneish M-Score - A statistical score that uses financial ratios to identify whether a company has manipulated its earnings
  • Cash Flow to Current Liabilities - A ratio that measures the amount of operating cash flow a firm generates on each dollar of current liabilities.
  • Total Debt / FCF - A ratio that is calculated as Total Debt (including Capital Leases) divided by levered free cash flow.
View Full List

Search for metric or datapoint

Debt / Equity

A ratio that measures the level of the debt relative to the book value of common equity.

Definition of Debt / Common Equity

Hide this widget

Debt / Equity is defined as:

Total Debt
(/) Total Common Equity
(=) Debt / Equity

Debt / Equity for Ekso Bionics is calculated as follows:

Total Debt [ 5.983 M]
(/) Total Common Equity [ 12.707 M ]
(=) Debt / Equity [ 47.1% ]

The tables below summarizes the trend in Ekso Bionics’s Debt / Equity over the last five years:

Fiscal Year Total Debt Total Common Equity Debt / Equity
2020-12-31 3.856 M 4.434 M 87.0%
2021-12-31 2.222 M 37.219 M 6.0%
2022-12-31 7.505 M 25.442 M 29.5%
2023-12-31 7.168 M 12.606 M 56.9%
2024-12-31 5.983 M 12.707 M 47.1%

The tables below summarizes the trend in Ekso Bionics’s Debt / Equity over the last four quarters:

Fiscal Quarter Total Debt Total Common Equity Debt / Equity
2024-03-31 6.842 M 14.051 M 48.7%
2024-06-30 6.691 M 12.059 M 55.5%
2024-09-30 6.346 M 14.87 M 42.7%
2024-12-31 5.983 M 12.707 M 47.1%

The higher the ratio, the more debt the company has in its capital structure.

Read More on HBR: Debt / Equity Ratio


Click the link below to download a spreadsheet with an example Debt / Common Equity calculation for Ekso Bionics Holdings Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-333.4%-33.4%266.6%592.7%2006001,000

The chart above depicts the distribution of debt / common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,465 companies were considered in this analysis, and 2,372 had meaningful values. The average debt / common equity of companies in the sector is 28.1% with a standard deviation of 101.0%.

Ekso Bionics Holdings Inc's Debt / Common Equity of 47.1% ranks in the 73.9% percentile for the sector. The following table provides additional summary stats:

Debt / Common Equity In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,470
Included Constituents2,372
Min-332.6%
Max589.6%
Median7.2%
Mean28.1%
Standard Deviation101.0%

You can find companies with similar debt / common equity using this stock screener.

All rights reserved. Terms Of Use